Detalhe da pesquisa
1.
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.
N Engl J Med
; 374(17): 1647-60, 2016 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25830326
2.
Early viral replication in lymph nodes provides HIV with a means by which to escape NK-cell-mediated control.
Eur J Immunol
; 41(9): 2729-40, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21630248
3.
HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection.
J Virol
; 83(13): 6798-805, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19386717
4.
Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection.
J Virol
; 83(17): 8705-12, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19553339
5.
MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction.
Virology
; 406(1): 12-20, 2010 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20667578